Company
Dthera Sciences
Headquarters: San Diego, CA, United States
Employees: 1
CEO: Mr. Edward M. Cox CLP
Market Cap
$82,696
USD as of July 1, 2022
Dthera Sciences Categories
United States Healthcare BiotechnologyUnited States Healthcare United States Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Dthera Sciences operates as a digital therapeutic company in neurodegenerative diseases. It is developing DTHR-ALZ, a medical device for the mitigation of the symptoms of agitation and depression associated with Alzheimer's disease. The company is based in San Diego, California.
Top 1-year algo backtest: +358.81%
$10,000 in June 2023 would now be $45,881 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Dthera Sciences has the following listings and related stock indices.
Stock: OTC: DTHR wb_incandescent